🔴 Immunitybio is trading 4.42% down today as U.S. markets weaken

Immunitybio is trading 4.42% down now at $7.57 as U.S. markets weaken.

• The S&P 500 is down 0.58%, while the Nasdaq Composite is down 1.36%.
• The broader risk-off tone is the clearest explanation, rather than a newly reported company-specific catalyst.
• Immunitybio’s August 4 second-quarter report showed $50.7 million in net product revenue, up 92% year over year, and does not directly explain the August 18 move.